Trials / Withdrawn
WithdrawnNCT05022537
Trial of Efficacy of the RetroPerc Device
RetroPerc®-A Prospective, Multi-institutional Trial of Efficacy of the RetroPerc Device
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy of RetroPerc® in obtaining renal access for percutaneous nephrolithotomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | retrograde nephrostomy | this will consist of one visit to a urologist for retrograde nephrostomy placement using a Retroperc device with lithotomy performed in the same visit and follow up at 4 weeks and 6 months. |
| DEVICE | antegrade nephrostomy | this will consist of two visits, first to the interventional radiologist for antegrade nephrostomy placement followed by another visit to the urologist for lithotomy with follow up at 4 weeks and 6 months |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-03-01
- Completion
- 2026-12-01
- First posted
- 2021-08-26
- Last updated
- 2026-03-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05022537. Inclusion in this directory is not an endorsement.